Cited by 271Liver Disease and TransplantationGastrointestinal motility and disordersGut microbiota and health

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

Pérez-Paramo, María, Muñoz, Javier, Albillos, Agustín, Freile, Isabel, Portero, Francisca, Santos, Martín, Ortiz-Berrocal, José·2000·Hepatology

DOI 10.1002/hep.510310109

Open this paper in CoChat — free account

Abstract

Bacterial translocation appears to be an important mechanism in the pathogenesis of spontaneous infections in cirrhosis. Cirrhotic patients are commonly treated with β-adrenoceptor blockers, but the impact of this treatment in the factors promoting bacterial translocation has not been investigated. This study was aimed at investigating in cirrhotic rats with ascites the effect of propranolol on intestinal bacterial load, transit, and permeability of the bowel and on the rate of bacterial translocation. Bacterial translocation to mesenteric lymph nodes and intestinal bacterial overgrowth, permeability (urinary excretion of 99m Tc-diethylenetriaminepentaacetic acid [99m Tc-DTPA]), and transit (geometric center ratio of 51 Cr) were assessed in 29 rats with carbon tetrachloride (CCl 4) cirrhosis and 20 controls. These variables were then measured in 12 placebo- and in 13 propranolol-treated ascitic cirrhotic rats. Bacterial translocation was present in 48% of the cirrhotic rats and in none of the controls. Cirrhotic rats with intestinal bacterial overgrowth had a significantly higher rate of translocation and slower intestinal transit than those without it. Among the 15 rats with overgrowth and a 99m Tc-DTPA excretion greater than 10%, 15 had translocation and 2 had bacterial peritonitis. Only 1 of the 14 rats with either intestinal overgrowth or a 99m Tc-DTPA excretion greater than 10% presented translocation. Compared with the placebo group, propranolol-treated animals had significantly lower portal pressure, faster intestinal transit, and lower rates of bacterial overgrowth and translocation. In ascitic cirrhotic rats, bacterial translocation results from intestinal overgrowth and severe damage to gut permeability. In this setting, intestinal overgrowth is associated with intestinal hypomotility. Propranolol accelerates the intestinal transit, decreasing the rates of bacterial overgrowth and translocation.

Integrity signals

Registry

Crossref · 10.1002/hep.510310109

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Increased Intestinal Permeability Associated With Infection in Burn Patients
Ziegler, T. R. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400350027003 · Cited by 316
Accurate measurement of intestinal transit in the rat
Miller, M. S., Galligan, J. J., & Burks, T. F. (1981) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(81)90110-8 · Cited by 288
High Yield Micronodular Cirrhosis in the Rat
Proctor, E., & Chatamra, K. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80126-1 · Cited by 286
Small Intestine Dysmotility and Bacterial Overgrowth in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
Chang, C., Chen, G., Lien, H., & Yeh, H. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
García–Tsao, G., Lee, F., Barden, G. E., Cartun, R. W., & West, A. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90147-7 · Cited by 247
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
Morencos, F. C., Castano, G. D. L. H., Ramos, L. M., Arias, M. J. L., Ledesma, F., & Romero, F. P. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02282340 · Cited by 246
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
Guarner, C., Runyon, B. A., Young, S., Heck, M., & Sheikh, M. Y. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80474-6 · Cited by 237
Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis
Runyon, B. A., Squier, S. U., & Borzio, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80241-6 · Cited by 218

Flagged first, then by citations

Show all 25 references

Sorted by citations

Items 201–270 of 270

Probiotics: Application of “healthy” bacteria to liver transplant recipients
Levitsky, J. (2006) · Hepatology · doi:10.1002/hep.21256 · Cited by 6
Consecuencias patogénicas de la translocación bacteriana en la cirrosis hepática
Albillos, A., de la Hera, A., & Álvarez‐Mon, M. (2001) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(01)79001-2 · Cited by 6
Self-citation
Hyponatremia in patients with acute variceal bleeding treated with terlipressin
Sharma, P., Singh, S. A., & Sarin, S. K. (2010) · Hepatology · doi:10.1002/hep.24116 · Cited by 6
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension
Xirouchakis, E., Kranidioti, H., Hadziyanni, E., Κourikou, A., Reppas, C. I., Vertzoni, M., Papadopoulos, N., Deutsch, M. J., Papatheodoridis, G., & Manolakopoulos, S. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03483-6 · Cited by 5
Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy
Lee, P., Chen, Y., Chou, Y., Lee, K., Chen, P., Kao, W., Huang, Y., Huo, T., Lin, H., Hou, M., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001511 · Cited by 5
Problemas actuales en la prevención y tratamiento de las infecciones en pacientes con cirrosis
Bellot, P., López, N. J. P., Martínez‐Moreno, B., & Such, J. M. (2010) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2010.02.004 · Cited by 5
Systemic inflammation in absence of gut bacterial translocation in C57BL/6 mice with cirrhosis
Cantera, M., Lario, M., Muñoz, L., Díaz, D., Borrero, M. J., García‐Bermejo, L., Álvarez‐Mon, M., & Albillos, A. (2012) · Gut · doi:10.1136/gutjnl-2012-302920 · Cited by 5
Self-citation
Infectious Complications of Portal Hypertension
Incicco, S., Angeli, P., & Piano, S. S. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.03.007 · Cited by 4
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
Allaire, M., Taddei, T. H., Thabut, D., & García–Tsao, G. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01209-5 · Cited by 4
HVPG Measurements as a Surrogate of Clinical Events in Cirrhosis: Experience from Clinical Trials
Delgado, M., & Bosch, J. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00461-5 · Cited by 4
Una mirada actual a la peritonitis bacteriana espontanea
Cardona, A. H., Guerra, J. J. H., & Restrepo, J. C. (2016) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.56 · Cited by 4
Non-selective β-blockers reduce bacterial translocation by restoring gut barrier function during experimental cirrhosis
Castillo, E., Felber, M., Paule, L., Juanola, O., Wyss, L., Wolfisberg, T., Christensen, S., Muñoz, L., Miranda, A., Alonso, M. P., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.07.019 · Cited by 3
Self-citation
Lipid peroxidation and liver damage in double and simple common bile duct ligation models in male Sprague-Dawley rats
Seguí‐Ripoll, J. M., Candela, A., Compañy-Catalá, L., Francés, R., Romá, A. P., Compañ, A., Such-Ronda, J. F., & Zapater, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122238 · Cited by 3
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure
Pohl, J., Aretakis, D., Tacke, F., Engelmann, C., & Sigal, M. J. (2025) · Seminars in Liver Disease · doi:10.1055/a-2516-2361 · Cited by 3
Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites
Alexiou, O. (2024) · Annals of Gastroenterology · doi:10.20524/aog.2024.0881 · Cited by 4
Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers
Vidal-González, D., Pérez-López, K. P., Vera-Nungaray, S. A., & Madrigal, L. G. M. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.02.004 · Cited by 3
Novel machine learning-based point-score model as a non-invasive decision-making tool for infected ascites in patients with hydropic decompensated liver cirrhosis: A retrospective multicentre study.Preprint
Würstle, S. M., Hapfelmeier, A., Karapetyan, S., Studen, F., Isaakidou, A., Schneider, T., Schmid, R. M., von Delius, S., Gundling, F., Triebelhorn, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1930434/v1 · Cited by 3
Nonselective beta blockade enhances gut microbiome diversity in a rodent model of trauma, hemorrhage, and chronic stress
Munley, J. A., Kelly, L. S., Park, G., Pons, E. E., Apple, C. G., Kannan, K. B., Bible, L. E., Efron, P. A., Nagpal, R., & Mohr, A. M. (2024) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004461 · Cited by 2
Single versus double experimental bile duct ligation model for inducing bacterial translocation
Seguí‐Ripoll, J. M., Zapater, P., Candela-Gomis, A., Compañ-Catalá, L., Francés, R., Romá, A. P., Compañ, A., & Such-Ronda, J. F. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.09.034 · Cited by 2
Bacterial Translocation and Alterations of the Digestive System
Wiest, R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_10 · Cited by 2
Ruptures de varices œsogastriques : histoire naturelle, physiopathologie et prophylaxies
Dib, N., Oberti, F., & Calès, P. (2007) · EMC - Hépatologie · doi:10.1016/s1155-1976(07)40565-4 · Cited by 2
Variceal Rebleeding: Drugs, Endoscopy or Both
Bendtsen, F., Møller, S., & Krag, A. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0002-2_16 · Cited by 2
Ameliorating Effect of a Beta-Blocker, Propranolol on Carbamazepine-Induced Hepatotoxicity in Rabbits
Abrar, H., Naqvi, S. N. H., Ahmed, M. R., Ali, A. B., & Yasin, H. (2019) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/2019.51.1.341.346 · Cited by 2
Experimental Models of Spontaneous Bacterial Peritonitis
Albillos, A., de la Hera, A., & Álvarez‐Mon, M. (2005) · Wiley eBooks · doi:10.1002/9780470987476.ch33 · Cited by 3
Self-citation
Failure of acarbose in preventing bacterial translocation in experimental cirrhosis
Sevá‐Pereira, T., Fernández, J., Navasa, M., Vilà, J., & Rodés, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00234-4 · Cited by 2
Esmolol increases the fecal abundance of Lactobacillus in a rat model of sepsis
Yao, B., Wang, F., Han, X., Yang, J., Xue, P., Qi, Q., Wei, G., & Xing, J.-Y. (2024) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00589-1 · Cited by 1
Spontaneous Bacterial Peritonitis and Other Infections in Cirrhosis
Morillas, R. M., & Planas, R. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-885-4_21 · Cited by 1
Spontaneous Bacterial Peritonitis: Is It Still A Life-Threatening Issue in Cirrhosis?
Ribeiro, T. C. D. R. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.616 · Cited by 1
Surgical outcomes of distal splenorenal shunt or liver transplantation in treatment of schistosomal refractory variceal bleeding
Doush, W. M. A., & Elzien, J. A. (2018) · Journal of Unexplored Medical Data · doi:10.20517/2572-8180.2017.18 · Cited by 1
The Gut Microbiome and Cirrhosis: Basic Aspects
Wiest, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-23018-4_18 · Cited by 2
Effects and Interactions of Ginger and Propranolol in Pre-Hepatic Portal Hypertensive Rats
Abdelsameea, A. A. (2015) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.1000179 · Cited by 1
Diuretic window hypothesis in cirrhosis: Changing the point of view
Brito‐Azevedo, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i26.3283 · Cited by 1
A comparative evaluation of the effectiveness of aspiration and automatic systems for percutaneous liver biopsy in experimental rats
Zhdanov, K. V., Saulevich, A. V., Karev, V. E., Kozlov, K. V., Zaharkiv, Y. F., Zakharenko, S. M., Lyashenko, Y. I., Ivanov, K. S., Sukachev, V. S., Shakhmanov, D. М., et al. (2019) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma25933 · Cited by 1
Spontaneous bacterial peritonitis — A disease of the gut? Therapeutic implications
Fernández, J., Cárdenas, A., & Ginès, P. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_25 · Cited by 1
Investigational drugs in early clinical development for portal hypertension
Rodrigues, S. G., Mendoza, Y. P., & Bosch, J. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2095259 · Cited by 1
The complexity of fatigue
Jones, D. E. J., & Newton, J. L. (2010) · Hepatology · doi:10.1002/hep.23906 · Cited by 1
On the role of intestinal hyperpermeability in complications of cirrhosis
Assimakopoulos, S. F. (2012) · Liver International · doi:10.1111/liv.12094 · Cited by 1
Análise dos fatores de risco para peritonite bacteriana espontânea em pacientes cirróticos e do perfil da flora infectante com o uso de antibióticos profiláticos
Sposeto, V. B. B. (2009) · doi:10.11606/d.5.2009.tde-29092009-172840 · Cited by 1
Propranolol Treatment is Associated with Better Survival in Cirrhotic Patients with Hepatic EncephalopathyPreprint
Lee, P.-C. L., Chen, Y.-J., Cho, Y.-C., Lee, K., Chen, P., Kao, W., Huang, Y., Huo, T., Lin, H.-C., Hou, M., et al. (2018) · Preprints.org · doi:10.20944/preprints201812.0278.v1 · Cited by 1
Bacterial Infections in Portal Hypertension
Fernández, J., & Navasa, M. (2007) · doi:10.1002/9780470691861.ch7i
Effects and Interactions of Ginger and Propranolol in Pre-Hepatic Portal Hypertensive Rats
El-Menshawy, S., El-Baroudy, N. H. F. E.-B., Fayed, F. A., Ali, A. I., Abdelsameea, A. A., Abdel-Aal, M., Pasha, H. F., & Emara, M. W. (2015) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2015.04.558
Lecture: Spontaneous Bacterial Peritonitis/Infections in Cirrhosis
Navasa, M., & Rodés, J. (2006) · doi:10.1002/9780470988831.ch10
The Effect of Domperindone on Intestinal Motility and Bacterial Overgrowth in Patients with Liver Cirrhosis
Mulyadi, Y., Gani, R. A., Abdullah, M., & Shatri, H. (2012) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/1332012130-135
Mediadores vasoactivos producidos por macrófagos peritoneales de pacientes cirróticos. Implicaciones fisiopatológicas.
Martín, C., & del Pilar, M. (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Microbiote intestinal et stéatopathies métaboliques
Hamza, S., Devilliers, H., Besancenot, J.-F., & Hillon, P. (2013) · Médecine thérapeutique · doi:10.1684/met.2013.0424
Bêtabloquants dans l’hypertension portale : des restrictions inattendues !
Thévenot, T., Cervoni, J., & Martino, V. D. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2010.10.003
Cirrosis hepática: medidas preventivas de algunas de sus complicaciones
Toledo, A. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70597-6
PREBIÓTICOS Y PROBIÓTICOS: MECANISMOS DE ACCIÓN Y SUS APLICACIONES CLÍNICAS
Clínicas, E. I. (2016)
TESIS PARA OPTAR AL GRADO DE DOCTOR DE
de Medicina, D., & de Medicina, F. (2015)
Paper del receptor de cannabinoides 1 (CB1) a la Cirrosi experimental : efecte del bloqueig de CB1 sobre les complicacions de la cirrosi
Garcia, G. Ò. (2011) · TDX (Tesis Doctorals en Xarxa)
A Case of Bacterial Translocation, Caused by Congestive Heart Failure with Aortic Valve Stenosis：A Case Report
Tarao, K., SHIMIZU, T., Kentaroh, I. I. D. A., & Son, K. (2017) · THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · doi:10.2199/jjsca.37.311
Current Trends in the Management of Spontaneous Bacterial Peritonitis
Ho, C. K., & Asrani, S. K. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0355-9
EFFECT OF GINGER AND PROPRANOLOL ON EXPERIMENTALLY INDUCED PORTAL HYPERTENSION IN ADULT MALE ALBINO RATS
El-Menshawy, S., El-Barody, N., Fayed, F., Ali, A., El-Den, H., Abdelaal, M., Basha, H., E-Shal, A., & Emara, M. M. (2014) · Egyptian Society of Clinical Toxicology Journal · doi:10.21608/esctj.2014.62849
Estimation of Correlation of Expression of Portal Hypertension and Concentration of Intestinal Endotoxin in Patients with Alcohol-Associated Liver Disease
Pavlov, A. I., Бакирова, В. Э., Khovanov, A. V., Khavanshanov, A. K., Fadina, Z. V., & Shames, A. B. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-15-34-39
Therapeutic Monitoring of Portal Pressure Lowering Drugs Using Liver Stiffness
Elshaarawy, O., Piecha, F., & Mueller, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_52
Preface
Lebrec, D. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.07.008
Ανίχνευση και ταυτοποίηση με κλασικές και μοριακές τεχνικές του αιτιολογικού παράγοντα της αυτόματης βακτηριακής περιτονίτιδας σε ασθενείς με κίρρωση
Μάλλη, Ε. (2019) · doi:10.12681/eadd/45300
Reply
Solà, E., Lens, S., Guevara, M., & Ginès, P. (2011) · Hepatology · doi:10.1002/hep.24168
Prevention of first variceal bleeding
Calès, P., Dib, N., & Oberti, F. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_20
Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers
Vidal-González, D., Pérez-López, K. P., Vera-Nungaray, S. A., & Madrigal, L. G. M. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.02.003
Evaluation of the Impact of the Sole Presence of Infection (Without Accompanying Decompensation) in the Natural History of Compensated Cirrhosis
Mendoza, Y. P., Ripoll, C., & Rodrigues, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-031-08552-9_30
Pathophysiology of portal hypertension in liver cirrhosis
Bernardi, M., & Zaccherini, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21938-2.00004-7
Influencia de la descontaminación intestinal selectiva con norfloxacina como profilaxis de la peritonitis bacteriana espontánea en la epidemiologia de las infecciones bacterianas en pacientes cirróticos
Almenar, V., & de, F. (2005)
Recompensation of Liver Cirrhosis: Definition, Mechanism, Etiological Differences, Prognosis, and Challenges
Zhou, D., Ba, K., Jia, T., Shen, Y., & Yang, L. (2026) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/8512168
Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis
Zhu, Y., Gao, W., Cheng, M., Li, X., Cai, K., Chen, L., & Chu, H. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06098-0 · Cited by 1
Gut dysbiosis and nitric oxide dysregulation in cirrhosis progression: mechanistic insights and pathophysiological implications
Răzniceanu, V., Țichindeleanu, A., Răducu, E.-V., Trella, Ș. E., & Nenu, I. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01188-w
Optimizing a carbon source based on water temperature to reduce Vibrio abundance and promote beneficial bacteria in a Penaeus vannamei shrimp biofloc system in China: a preliminary study
Ghonimy, A., Chen, Z., Greco, L. S. L., Dyzenchauz, F. J., & Li, J. (2026) · Frontiers in Systems Biology · doi:10.3389/fsysb.2026.1819518
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis
Incicco, S., Patidar, K. R., Juanola, A., Ma, A. T., Barone, A., Kulkarni, A. V., Pérez-Hernández, J. L., Asrani, S. G., Wentworth, B. J., Alessandria, C., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.06.043
Crosstalk along the gut–liver axis in liver disease: Clinical and mechanistic aspects
Nakamoto, N., Okada, H., Bäckhed, F., Schnabl, B., & Hov, J. R. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.10.019
Inhibition of nitric-oxide-mediated vasodilation (including K+ channels)
Moreau, R. (2004) · Springer eBooks · doi:10.1007/978-94-007-1042-9_16

Authors: Pérez-Paramo, M., Muñoz, J., Albillos, A., Freile, I., Portero, F., Santos, M., & Ortiz-Berrocal, J.
ORCID: Muñoz, Javier
Santos, Martín
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-01
Volume: 31
Issue: 1
Pages: 43-48
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.510310109
OpenAlex: W2003357282
Cited by: 271
References: 25
Citations by year: 2026: 8 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 11 · 2019: 16 · 2018: 13 · 2017: 11 · 2016: 19 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 16
FWCI: 5.36
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5722 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Funders: Fondo de Investigaciones Sanitarias (99/0356)
Universidad de Alcalá (E001/98 y E002/99)
Programa Nacional de Salud from the Comisión Interministerial de Ciencia y Tecnología
Topics: Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: propranolol, bacterial translocation, liver cirrhosis, ascites, beta-blockers, intestinal bacterial overgrowth, intestinal transit, intestinal permeability, portal hypertension, spontaneous bacterial peritonitis, mesenteric lymph nodes
MeSH terms: Animals, Bacteria, Carbon Tetrachloride, Intestinal Absorption, Intestines, Liver Cirrhosis, Experimental, Lymph Nodes, Male, Mesentery, Propranolol, Technetium Tc 99m Pentetate, Rats, Sprague-Dawley, Bacterial Translocation, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks